Immunology: Chapter 14 Flashcards
(52 cards)
Type I Hypersensitivity
IgE-mediated
Soluble antigen
Mast-cell activation
Basophils also participate (produce FceRI)
(Standard allergic response)
Hypersensitivity rection: allergic rhinitis, allergic asthma, atopic eczema, systemic anaphylaxis, some drug allergies
Type II Hypersensitivity
IgG-mediated
Innocuous agents bind to the surface of circulating blood cells
Antibody-mediated destruction of RBCs (hemolytic anemia) or platelets (thrombocytopenia) is an uncommon side-effect associated with certain drugs like penicillin
Antigen: Cell- or matrix-associated antigen
Opsonizes the cell and triggers clearance by macrophages in the spleen (Fc-gamma receptors for B antibodies)
Complement, FcR+ cells (phagocytes, NK cells)
Some drug allergies (e.g. penicillin)
Antigen: cell-surface receptor (or platelets)
Target for anti-drug IgG antibodies that cause destruction of cell
Antibody alters signaling
Chronic urticaria (antibody against FceRI alpha chain)
Type III Hypersensitivity
IgG-mediated
Soluble antigen
Caused by deposition of antigen:antibody aggregates (immune complexes) at certain tissue sites
Can cause systemic disease following the administration of large quantities of poorly catabolized antigens
Large antigen:antibody aggregates: readily cleared by mononuclear phagocytes, but smaller complexes cannot be phagocytosed
Small complexes: (prevalent at antigen excess): tend to deposit in blood vessel walls, where they can ligate Fc receptors on leukocytes
Leukocyte activation (local inflammatory response and tissue injury)
Complement, phagocytes
Hypersensitivity reaction: serum sickness, Arthus reaction
Types IV Hypersensitivity (Millis)
Most common type of IgE-independent allergic reactions; mediated by Th1 and CD8 cytotoxic T cells
Immune reactant: TH1 cells
Soluble antigen
Macrophage activation
Hypersensitivity reaction: allergic contact, dermatitis, tuberculin reaction
Immune reactant: TH2 cells
Soluble antigen
IgE production, eosinophil activation, mastocytosis
Hypersensitivity reaction: chronic asthma, chronic allergy rhinitis
Immune reactant: CTL
Cell-associated antigen
Cytotoxicity
Hypersensitivity reaction: graft rejection, allergic contact dermatitis to poison ivy
Allergic Reactions
(Type I): individual produces IgE antibody to an innocuous antigen (allergen), then encounters the same antigen
Atopy: Predisposition to become IgE-snesitized to environmental allergens
IgE, etc…
IgE is produced by plasma cells
Predominantly located in tissues; bound to mast-cell surfaces through high affinity IgE receptor FceRI
Further amplified by basophils and mast cells
Both express receptor FceRI (IgE binds with high affinity)
These cells are activated by cross-linking of FceRI receptor by antigen (express CD40 and secrete IL-4)
Binding of antigen cross-links receptors and causes release of chemical mediators from mast cells
Occurs at site of allergic reaction
B cells form germinal centers at inflammatory foci
Blocking this amplification process is a goal of therapy
Allergic reaction can otherwise become self-sustaining
Sensitization
Class switching to IgE production on 1st contact with an allergen
Atopic indiv: develop multiple allergic diseases to multiple allergens
Allergic reactions in non-apoptic: mainly due to sensitization to one specific allergen tat can develop any time in life
2 main components of Immune response –> IgE production
Signals that favor the differentiation of naive CD4 T cells –> TH2 cells
Cytokines and co-stimulatory signals from TH2 that stimulate B cells to switch to producing IgE antibodies
Signals that favor differentiation of TH2
IL-4, IL-5, IL-9, IL-13
Signals found mainly at sites of entry of parasites - under skin, under epithelial airway surfaces and in submucosa of gut
Interaction between dendritic and naive T cells –> polarization to TH2 cells
If antigen is encountered by dendritic cells in context of pro-inflammatory signals, dendritic cells produce TH1 polarizing cytokines (IL-12, IL-23, IL-27)
Switching of B cells to IgE requires..
IL-4 or IL-13 AND
Co-stimulatory interaction between CD40L on T cell surface and CD40 on B cell surface
Allergens
Derived transmucosally at low dose (favors IgE production)
All are proteins
Often proteases (break down epithelial barriers in connective tissues)
Selectively favors activation of TH2 cells
Ex: Maximum exposure to allergens in ragweed does not exceed 1ug per year
Low molecular weight, readily diffuse out of particles into mucus
High solubility (ready elution)
Stable and can survive in dessicated particles
This is how they are carried (pollen grains and mite feces)
Mut yield peptides that can be presented to MHC class II molecules
People can develop irritating and even life-threatening reaction to allergens in ragweed
Allergens (cont.)
Taken up my mucosal dendritic cells (process the protein antigens very efficiently and become activated)
Mast cells and eosinophils can present antigen to T cells
Ex: Major allergen in mite feces; Der p 1 (~20% of allergy in NA)
Cysteine protease
Helps breakdown intercellular tight junctions
May gain abnormal access to subepithelial cells (including APCs, resident mast cells, and eosinophils)
Netherton’s Disease
Characterized by high levels of IgE and multiple allergies
Cause by LACK of a protease inhibitor SPINK5
Papain
Cysteine protease from papaya (meat tenderizer) and causes allergies of workers preparing the enzyme
Ex of occupational allergy
Not ALL allergens are enzymes
2 allergens from filarial worms are enzyme inhibitors
** Largest concern of new GMO foods is the possibility that an introduced gene may produce a protein that is an allergen (ex: brazil nut)
Genetic factors contribute to development of IgE-mediated allergic diseases
Atopy: tendency to mount IgE responses to a wide variety of common environmental allergens
Higher total levels of IgE in circulation
Higher levels of eosinophils
More susceptible to hay fever and asthma
Environmental and genetic factors each contribute to ~50% of the risk
Genetic Factors
Susceptibility genes for: Atopic dermatitis and asthma
Little overlap between genes
Overlap between: atopic dermatitis and psoriasis & asthma and autoimmune diseases
Many predisposing genes may be involved in worsening inflammation
Candidate Susceptibility genes
Beta subunit of FceRI receptor (asthma & atopic dermatitis)
Gain-of-function mutation of alpha subunit if IL-4 receptor
Another region of chromosome contains 4 types of susceptibility genes:
1st set: cluster of tightly linked genes for cytokines that promote TH2 responses (enhances IgE class-switching), eosinophil survival and mast cell proliferation
Genes for: IL-3, IL-4, IL-5, IL-9, IL-13 and GM-CSF
Up-promoter mutation (increased promoter activity) of IL-4 gene leads to increased IgG levels in atopic indiv.
2nd set: TIM family of genes
Encode surface proteins on T cells
Inherited variation are correlated w/ airway hyperactivity
Non-specific irritant causes contraction of bronchial smooth muscle, similar to asthma
3rd set: encodes p40 (one subunit of IL-12)
IL-12 promotes TH1 responses and variant of p40 is associated w/ more severe asthma –> redued IL-12
4th set: encodes beta-adrenergic receptor
Alteration in smooth muscle responsiveness to various ligands
Inherited variation in IgE can be linked to MHC class II region
Affects responses to specific allergens, rather than susceptibility to atopy in general
IgE production in responses to specific allergens is associated with HLA class II alleles
Particular MHC:peptide combos might favor strong TH2 response
Ex: IgE responses to several ragweed pollen allergens (associated with haplotypes containignthe MHC class II allele DRB*1501)
** Many individuals are predisposed to developing allergies to specific allergens b/c of a particular MHC haplotype
Allergens to common drugs such as penicillin, show no association with:
MHC class II alleles
Presence or absence of atopy
Some genes are likely to affect only particular aspects of allergic disease
In asthma: different genes affect aspects of disease:
IgE production
Inflammatory response
Clinical responses to particular treatments
**Prevalence of atopic allergy, particularly asthma, is increasing in economically advanced regions of the world
‘Hygiene Hypothesis”
Exposure to infectious diseases in childhood is the key factor
TH2 responses predominate over TH1 responses by default, early in childhood
Less hygienic the environment, more infection in early childhood
Early infections reprogram system to TH1 dominated responses
Refers to infections that skew immune system towards TH1, as seen in large number of infections
Evidence AGAINST hygiene: Helminths (worms): strong drivers of TH2 reposes, but are protective against atopy
In Venezuela, children “dewormed” by chemical treatment for a long period of time are more susceptible to atopy than untreated and heavily parasitized children
“Counter-regulation hypothesis” (modification of hygiene)
Says all types of infection protect against development of atopy by driving production of cytokines Il-10 and TGF-beta, which drown regulate both TH1 and TH2 reposes
Decreased early exposure to common microbial pathogens and commensals makes body less efficient at making Treg cells
Evidence in Favor:
Bias toward TH2 responses in newborn infants
Many childhood infections help protect against development of atopic allergic disease
Atopy is less likely in people who were in groups of children at a young age
Atopy is negatively associated with:
Early colonization of gut with commensal bacteria (lactobacilli & bifidobacteria)
Infection with Toxoplasma gondii (stimulates TH1 response) and with H. Pylori
History of infection with measles virus, hepatitis A, positive tuberculin skin tests (prior exposure to TB)
Atopy is positively associated with:
Attacks of bronchiolitis associated with respiratory syncytial virus (RSV)
Children hospitalized with disease have skewed ratio of cytosine production towards IL-4 and away from IFN-gamma
Environmental Factors
Increase in allergy: Changes in diet Allergen exposure Atmospheric pollution Tobacco smoke